Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.
Martín-Sánchez E, Blanco L, Kim PS, Bisht K, Wang H, Van de Velde H, Jelinek T, Simoes C, Prosper F, San Miguel JF, Alfonso A, Bergua J, Rodríguez-Veiga R, Vives S, Martínez-Cuadrón D, Montesinos P, Paiva B, Zabaleta A.
Martín-Sánchez E, et al. Among authors: kim ps.
Blood Adv. 2024 Aug 13;8(15):3875-3879. doi: 10.1182/bloodadvances.2024013212.
Blood Adv. 2024.
PMID: 38815228
Free PMC article.
No abstract available.